← All stocks

Design Therapeutics, Inc.

DSGN Net buying
CIK 0001807120 #2568 in the set updated 22 Sep 2026
Bought (120 mo)
$62.19M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$17.71M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$17.71M
8 of 8 sales
Net
+$44.48M
+$44.48M against sales at will

By person

14 insiders · 35 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Cormorant Asset Management, LP entity
Former 10% Owner
$15.00M (1)
+$15.00M
5,114,844
8.17%
$26.85M
William Arsani
Director
$20.47M (5)
$6.42M (3)
+$14.05M
6,982,629
11.16%
$36.66M
+109.8%
George Simeon
Director
$12.57M (4)
+$12.57M
12,152,952
19.42%
$63.80M
+116.0%
SR One Capital Fund I Aggregator LP entity
10% owner
$12.57M (4)
+$12.57M
6,526,476
10.43%
$34.26M
Xu Stella
Director
$200.00K (1)
$11.27M (4)
−$11.07M
13,581,610
21.70%
$71.30M
+43.8%
Shah Pratik
President, CEO and Chairperson
$500.00K (1)
+$500.00K
154,923
0.2476%
$813.35K
+519.7%
Thacker Justin
Vice President, Finance
$350.00K (1)
+$350.00K
17,500
0.0280%
$91.88K
LAPPE RODNEY W
Director
$268.71K (3)
+$268.71K
133,024
0.2126%
$698.38K
+44.6%
Schmid John P.
Director
$99.74K (2)
+$99.74K
26,965
0.0431%
$141.57K
Siffert Joao MD
President and CEO
$62.50K (2)
+$62.50K
132,619
0.2119%
$696.25K
+6.0%
Jeffries Sean
Chief Operating Officer
$61.00K (1)
+$61.00K
3,050
0.0049%
$16.01K
Berger Heather A.
Director
$4.87K (1)
+$4.87K
1,300
0.0021%
$6.83K
Prasad Deepa
Director
$27.67K (1)
$23.86K (1)
+$3.81K
20,000
0.0320%
$105.00K
Quan Venture Fund II, L.P. entity
10% owner
4,720,830
7.54%
$24.78M

Nothing of that kind in this period.

What was left out

Form 4 filings counted 92
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 26,708,686
Sales filed before the plan box existed 4
History held since 29 Mar 2021